Madangamine A
Latest Information Update: 13 Jul 1998
At a glance
- Originator Nonindustrial source
- Class Alkaloids; Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 13 Jul 1998 Profile reviewed
- 13 Jul 1998 No-Development-Reported for Cancer in Canada (Unknown route)
- 16 Jan 1995 Preclinical development for Cancer in Canada (Unknown route)